Back to Search
Start Over
[Multiple myeloma with myelofibrosis at diagnosis and aggressive extramedullary relapse after autologous stem cell transplantation].
- Source :
-
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2024; Vol. 65 (1), pp. 1-6. - Publication Year :
- 2024
-
Abstract
- A 66-year-old man was diagnosed with symptomatic IgG-λ multiple myeloma based on the presence of anemia, thrombocytopenia, renal dysfunction, and a tumor on the right sixth rib. Bone marrow aspiration yielded a dry tap and biopsy revealed myelofibrosis grade 2. Partial response was achieved with Bd (bortezomib and dexamethasone) and VRd (bortezomib, lenalidomide, and dexamethasone). The patient received autologous stem cell transplantation, but the myeloma relapsed 3 months later, and liver tumors developed as well. DKd (daratumumab, carfilzomib, and dexamethasone) was administered, but the patient died due to disease progression. Autopsy revealed multiple extramedullary lesions in the liver, spleen, gallbladder, adrenal glands, kidneys, and multiple lymph nodes, as well as ascites.
- Subjects :
- Male
Humans
Aged
Bortezomib therapeutic use
Dexamethasone therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Neoplasm Recurrence, Local
Transplantation, Autologous
Multiple Myeloma complications
Multiple Myeloma diagnosis
Multiple Myeloma therapy
Hematopoietic Stem Cell Transplantation
Primary Myelofibrosis complications
Primary Myelofibrosis diagnosis
Primary Myelofibrosis therapy
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0485-1439
- Volume :
- 65
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- [Rinsho ketsueki] The Japanese journal of clinical hematology
- Publication Type :
- Academic Journal
- Accession number :
- 38311382
- Full Text :
- https://doi.org/10.11406/rinketsu.65.1